Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)
Clinical trial NCT02221258 · COMPLETED
Trial details
- NCT number
- NCT02221258
- Sponsor
- Kang Stem Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.